Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Delaitre

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Archives of Cardiovascular Diseases|June 29, 2014
Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspectiveJulie Chevalier, Olivier Delaitre, Florence Hammès, et al.
Therapie|February 18, 2020
From single-arm studies to externally controlled studies. Methodological considerations and guidelinesMichel Cucherat, Silvy Laporte, Olivier Delaitre, et al.
Therapie|February 18, 2020
Michel Cucherat, Silvy Laporte, Olivier Delaitre, et al.
Therapie|February 27, 2018
Marie-France Mamzer, Sophie Dubois, Christian Saout, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Archives of Cardiovascular Diseases|June 29, 2014
Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspectiveJulie Chevalier, Olivier Delaitre, Florence Hammès, et al.
Therapie|February 18, 2020
From single-arm studies to externally controlled studies. Methodological considerations and guidelinesMichel Cucherat, Silvy Laporte, Olivier Delaitre, et al.
Therapie|February 18, 2020
Michel Cucherat, Silvy Laporte, Olivier Delaitre, et al.
Therapie|February 27, 2018
Marie-France Mamzer, Sophie Dubois, Christian Saout, et al.
Pageof 1